Literature DB >> 10513822

Increased expression of multidrug resistance of P-glycoprotein on Th1 cells correlates with drug resistance in rheumatoid arthritis.

K Yudoh1, H Matsuno, F Nakazawa, T Yonezawa, T Kimura.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10513822     DOI： 10.1002/1529-0131(199909)42:9<2014::AID-ANR32>3.0.CO;2-R

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  15 in total

1.  Drug resistance in rheumatology: an area in search of investigators.

Authors:  Frank A Wollheim
Journal:  Curr Rheumatol Rep       Date:  2003-10       Impact factor: 4.592

Review 2.  Glucocorticoid sensitivity in health and disease.

Authors:  Rogier A Quax; Laura Manenschijn; Jan W Koper; Johanna M Hazes; Steven W J Lamberts; Elisabeth F C van Rossum; Richard A Feelders
Journal:  Nat Rev Endocrinol       Date:  2013-10-01       Impact factor: 43.330

3.  Clinical relevance of P-glycoprotein activity on peripheral blood mononuclear cells and polymorphonuclear neutrophils to methotrexate in systemic lupus erythematosus patients.

Authors:  Mario García-Carrasco; Claudia Mendoza-Pinto; Salvador Macías-Díaz; Ivet Etchegaray-Morales; Socorro Méndez-Martínez; Pamela Soto-Santillán; Beatriz Pérez-Romano; Erick A Jiménez-Herrera; Omar Guzmán-Ruiz; Alejandro Ruiz-Argüelles
Journal:  Clin Rheumatol       Date:  2017-06-14       Impact factor: 2.980

4.  The effect of 3435C>T MDR1 gene polymorphism on rheumatoid arthritis treatment with disease-modifying antirheumatic drugs.

Authors:  Marek Drozdzik; Tomasz Rudas; Andrzej Pawlik; Mateusz Kurzawski; Bogusław Czerny; Wanda Gornik; Magdalena Herczynska
Journal:  Eur J Clin Pharmacol       Date:  2006-08-24       Impact factor: 2.953

5.  Down regulation of multidrug resistance protein-1 expression in patients with early rheumatoid arthritis exposed to methotrexate as a first disease-modifying antirheumatic drug.

Authors:  S L Hider; A Owen; R Hartkoorn; S Khoo; D Back; A J Silman; I N Bruce
Journal:  Ann Rheum Dis       Date:  2006-02-27       Impact factor: 19.103

6.  Multidrug resistance 1 (MDR1) 3435C>T gene polymorphism influences the clinical phenotype and methotrexate-induced adverse events in South Indian Tamil rheumatoid arthritis.

Authors:  Niveditha Muralidharan; Paul T Antony; Vikramraj K Jain; Christina Mary Mariaselvam; Vir Singh Negi
Journal:  Eur J Clin Pharmacol       Date:  2015-06-14       Impact factor: 2.953

Review 7.  Neuroendocrine-immune interactions in rheumatoid arthritis: mechanisms of glucocorticoid resistance.

Authors:  Marni N Silverman; Esther M Sternberg
Journal:  Neuroimmunomodulation       Date:  2008-07-29       Impact factor: 2.492

8.  Acquired resistance of human T cells to sulfasalazine: stability of the resistant phenotype and sensitivity to non-related DMARDs.

Authors:  J van der Heijden; M C de Jong; B A C Dijkmans; W F Lems; R Oerlemans; I Kathmann; G L Scheffer; R J Scheper; Y G Assaraf; G Jansen
Journal:  Ann Rheum Dis       Date:  2004-02       Impact factor: 19.103

9.  Expression of resistance markers to methotrexate predicts clinical improvement in patients with rheumatoid arthritis.

Authors:  J Wolf; T Stranzl; M Filipits; G Pohl; R Pirker; B Leeb; J S Smolen
Journal:  Ann Rheum Dis       Date:  2004-09-02       Impact factor: 19.103

10.  Expression of multidrug resistance-1 protein correlates with disease activity rather than the refractoriness to methotrexate therapy in rheumatoid arthritis.

Authors:  V Agarwal; S K Mittal; R Misra
Journal:  Clin Rheumatol       Date:  2009-01-10       Impact factor: 2.980
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.